PFIZER'S NEW PRESCRIPTION AID TO SMOKING CESSATION TREATMENT CHANTIX™ (VARENICLINE) NOW AVAILABLE IN U.S. PHARMACIES

Story Summary:

Pfizer announced today that its new prescription aid to smoking cessation treatment CHANTIX™ (varenicline) is now available in U.S. pharmacies. CHANTIX is the first new prescription aid to smoking cessation treatment approved by the U.S. Food and Drug Administration in nearly a decade.

Patients taking CHANTIX will have the opportunity to enroll in a behavioral support program called the GETQUIT^TM Support Plan, which is designed to help educate patients about managing cravings and behavioral triggers. This program will be available at no additional cost to patients taking CHANTIX, and will be easy for patients to use, with both online and telephone interaction capabilities.

For full prescribing information, patients and health care providers can visit www.CHANTIX.com or call 1-877-CHANTIX to receive more information about CHANTIX.

Soundbites

• Joe Maloof, Clinical trial participant

B-Roll Includes

• Product Shots
• Smokers

VIDEO PROVIDED BY: "Pfizer Inc"